Home/ Stocks/ CBUS

Cibus, Inc. Class A Common Stock

CBUS XNAS

$1.81 -0.06 (-3.21%) ▼ 15-min delayed

Open

$1.89

High

$1.89

Low

$1.75

Volume

163.5K

Market Cap

$142.74M

About Cibus, Inc. Class A Common Stock

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Sector: AGRICULTURAL CHEMICALS Employees: 118 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$1.68M	$-21,222,000	$-0.33
Q3 2025	$615.0K	$-24,303,000	$-0.44
Q2 2025	$933.0K	$-26,558,000	$-0.61
Q1 2025	$1.03M	$-49,392,000	$-1.34

Related Market News

No specific coverage for CBUS yet. Check out our latest market news or earnings calendar.

Get CBUS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Cibus, Inc. Class A Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.